What is Klotho Neurosciences, Inc.?
develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 30.91M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.